Navitor Pharmaceuticals Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Navitor Pharmaceuticals, Inc., is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways.  The company’s proprietary drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth.  Navitor’s therapeutics are designed to selectively modulate the cellular signals that are aberrant in disease processes caused by the dysregulation of mTORC1 activity to address a wide range of diseases, including metabolic, CNS, autoimmune and musculoskeletal diseases, as well as several rare disorders.   The company is backed by leading financial and corporate investors, including Polaris Partners, Atlas Venture, J&J Innovation - JJDC, SR One, Brace Pharma Capital, Remeditex ventures, Sanofi Ventures and The Longevity Fund.

✕

Access Insights for Navitor Pharmaceuticals and Millions of Other Companies

Sign up for full access to Navitor Pharmaceuticals information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory